CLINICAL ROLE -
Clinical Overview: Baricitinib (Olumiant) for Rheumatoid Arthritis, COVID-19
Baricitinib (Olumiant) is indicated for the treatment of rheumatoid arthritis and COVID-19 in hospitalized adults.
Read More
Clinical Overview: Lifitegrast Ophthalmic Solution (Xiidra) for Dry Eye Disease
In clinical trials, Xiidra was found to improve eye dryness scores significantly compared with placebo.
Clinical Overview: Daridorexant for the Treatment of Insomnia
The FDA approved daridorexant in January 2022 to treat insomnia after it showed improvements in changes in latency to persistent sleep and wake after sleep onset.